The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers

Background: This updated meta-analysis aimed to analyze available data to explore the prognostic value of long noncoding RNA breast cancer anti-estrogen resistance 4 (BCAR4) in various human malignancies. Methods: Literature retrieval was performed by systematic searching several authoritative datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Chao, Ren, Xiaolei, He, Jieyu, Zhang, Chenghao, Chen, Ruiqi, Wang, Wanchun, Li, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856575/
https://www.ncbi.nlm.nih.gov/pubmed/31762809
http://dx.doi.org/10.7150/jca.35113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856575/
https://www.ncbi.nlm.nih.gov/pubmed/31762809
http://dx.doi.org/10.7150/jca.35113

Ejemplares similares